Cargando…
Atypical Dermatitis Herpetiform and Scalp Psoriasis in Ulcerative Colitis Patient Treated With Adalimumab
Adalimumab is a blocker of tumor necrosis factor (TNF)-alpha with established efficacy in the treatment of ulcerative colitis. However, literature indicated that adalimumab can, occasionally, induce paradoxical psoriasis reactions and, very rarely, dermatitis herpetiformis. We present a unique case...
Autores principales: | Alshehri, Hamza, Alshehri, Afnan, bin Abbas, Abrar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947429/ https://www.ncbi.nlm.nih.gov/pubmed/36846641 http://dx.doi.org/10.7759/cureus.35317 |
Ejemplares similares
-
Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence
por: Lombardi, G, et al.
Publicado: (2016) -
A large scalp ulceration
por: Guerra, Karla, et al.
Publicado: (2021) -
Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study
por: Phan, Duc Binh, et al.
Publicado: (2023) -
Patient with treatment resistant peristomal and scalp dermatitis
por: Jung, Joo, et al.
Publicado: (2022) -
Psoriasis in Saudi Population: Gender Differences in Clinical Characteristics and Quality of Life
por: Alamri, Awadh, et al.
Publicado: (2022)